Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model.

[1]  Wei-Chiang Shen,et al.  Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives , 2007, Pharmaceutical Research.

[2]  J. Sutcliffe,et al.  Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). , 2007, Nuclear medicine and biology.

[3]  Michael J Sailor,et al.  Biomimetic amplification of nanoparticle homing to tumors , 2007, Proceedings of the National Academy of Sciences.

[4]  Janos Szebeni,et al.  Methylation of the phosphate oxygen moiety of phospholipid‐methoxy(polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin production , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Liang Li,et al.  Three-layer matrix/sample preparation method for MALDI MS analysis of low nanomolar protein samples , 2006, Journal of the American Society for Mass Spectrometry.

[6]  N. Goldstein,et al.  Identification of cancer targets and therapeutics using phage display. , 2006, Current opinion in drug discovery & development.

[7]  Silvia Muro,et al.  Advanced drug delivery systems that target the vascular endothelium. , 2006, Molecular interventions.

[8]  M. Wauben,et al.  Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. , 2006, Arthritis and rheumatism.

[9]  Wadih Arap,et al.  Vascular Targeting: Recent Advances and Therapeutic Perspectives , 2006, Trends in Cardiovascular Medicine.

[10]  E. Ruoslahti,et al.  Molecular Profiling of Heart Endothelial Cells , 2005, Circulation.

[11]  Simon C Watkins,et al.  Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[13]  R. Marchant,et al.  RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system , 2004, Thrombosis and Haemostasis.

[14]  Vladimir P Torchilin,et al.  Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[15]  E. Ruoslahti,et al.  Vascular zip codes in angiogenesis and metastasis. , 2004, Biochemical Society transactions.

[16]  A. Bao,et al.  Direct 99mTc Labeling of Pegylated Liposomal Doxorubicin (Doxil) for Pharmacokinetic and Non-Invasive Imaging Studies , 2004, Journal of Pharmacology and Experimental Therapeutics.

[17]  Mouldy Sioud,et al.  Selective targeting of cancer cells using synthetic peptides. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[18]  R. Schiffelers,et al.  Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[19]  F. Pastorino,et al.  Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma. , 2003, Cancer letters.

[20]  L. Cipelletti,et al.  Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. , 2002, Blood.

[21]  M. Shive,et al.  Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Erkki Ruoslahti,et al.  Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature , 2001, Arthritis research.

[23]  J. Logan Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.

[24]  J. Kamps,et al.  Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[26]  S. Kennel,et al.  Lipid composition is important for highly efficient target binding and retention of immunoliposomes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Bao,et al.  Complexes: In Vitro Stability, Imaging, and Biodistribution in Rats , 2003 .

[28]  Sutcliffe-Goulden Jl,et al.  The synthesis of novel 18F-labelled peptides for PET. , 2002 .

[29]  W. Chan,et al.  Fmoc Solid Phase Peptide Synthesis: A Practical Approach (Practical Approach Series) , 2019 .

[30]  C. Tilcock,et al.  99mTc-labeling of lipid vesicles containing the lipophilic chelator PE-DTTA: effect of tin-to-chelate ratio, chelate content and surface polymer on labeling efficiency and biodistribution behavior. , 1994, Nuclear medicine and biology.